Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria
収録刊行物
-
- The Journal of Allergy and Clinical Immunology: In Practice
-
The Journal of Allergy and Clinical Immunology: In Practice 4 (3), 529-530, 2016-05
Elsevier BV